Prevention of Restenosis After Genous Stent Implantation Using a Paclitaxel Eluting Balloon in Coronary Arteries - a Randomized Clinical Trial.

Trial Profile

Prevention of Restenosis After Genous Stent Implantation Using a Paclitaxel Eluting Balloon in Coronary Arteries - a Randomized Clinical Trial.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 17 Jul 2014

At a glance

  • Drugs Anti-CD34 monoclonal antibody; Paclitaxel
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms PERfECT-STENT
  • Most Recent Events

    • 09 Jun 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
    • 27 Mar 2012 Results presented at the 61st Annual Scientific Session of the American College of Cardiology.
    • 26 May 2011 Results published in Heart.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top